Disopyramide Sustained-Release Capsules and Indium DTPA
Determining the interaction of Disopyramide Sustained-Release Capsules and Indium DTPA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111, In-111 DTPA
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Disopyramide Sustained-Release Capsules-Indium In-111 Pentetreotide
- Disopyramide Sustained-Release Capsules-Indium Oxyquinoline
- Disopyramide Sustained-Release Capsules-Indocid
- Disopyramide Sustained-Release Capsules-Indocin
- Disopyramide Sustained-Release Capsules-Indocin (Indomethacin Suppositories)
- Disopyramide Sustained-Release Capsules-Indocin (Indomethacin Suspension)
- Indium DTPA-DisperMox
- Indium DTPA-Disposable Enema rectal
- Indium DTPA-Disulfiram
- Indium DTPA-Dithol Solution
- Indium DTPA-Ditropan
- Indium DTPA-Ditropan XL